13F COMBINATION REPORT
DC Funds, LP
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0001398344-24-020741
Total Value
$5.2M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | TSCAN THERAPEUTICS INC | TCRX | 630,000 | $3.1M | 60.91% |
| 2 | WEREWOLF THERAPEUTICS INC | HOWL | 589,102 | $1.2M | 24.25% |
| 3 | BARINTHUS BIOTHERAPEUTICS PL | BRNS | 642,204 | $764,223 | 14.84% |